Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Also known as: Thrombotic Thrombocytopenic Purpura, Acquired / Acquired Thrombotic Thrombocytopenic Purpura

DrugDrug NameDrug Description
DB06081CaplacizumabA von Willebrand factor (vWF)-directed antibody fragment used to treat acquired thrombotic thrombocytopenic purpura (aTTP).
DrugDrug NameTargetType
DB06081Caplacizumabvon Willebrand factortarget
DrugDrug NamePhaseStatusCount
DB15094Anfibatide2Not Yet Recruiting1
DB15164Apadamtase alfa2Completed1
DB06081Caplacizumab2Completed1
DB06081Caplacizumab2Not Yet Recruiting1
DB06081Caplacizumab3Completed2
DB00188Bortezomib4Not Yet Recruiting1
DB06081CaplacizumabNot AvailableRecruiting1